Biomarkers of acute kidney injury. Kidney diseases represent an important clinical problem,
with increasing incidence and high mortality rate. Despite encouraging results on acute …

The incidence of obesity has increased globally in children and adults. In addition, renal
dysfunction is an important complication of childhood obesity. This study was performed to …

Urinary enzyme activities, especially N-acetyl-β-D-glucosaminidase (NAG), had been shown
to be a useful early marker of renal injury in clinical diagnosis. 1, 2 NAG is a lysosomal …

BACKGROUND Measurement of total urinary protein, glucose, and the appearance of
certain enzymes such as N-acetyl-β-(D)-glucosaminidase has been used in both animals …

N-acetyl-beta-D-glucosaminidase (NAG) is a lysosomal enzyme present in the proximal
convoluted tubules of the kidneys that may be used as a marker of proximal tubular damage …

Urinary biomarkers can predict the progression of chronic kidney disease (CKD). In this
study, kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL) …

Screening for diabetic kidney disease (DKD) remains a challenge; however, there has been
an ongoing research to investigate the diagnostic value of different biomarkers to identify …

There is a paucity of sensitive and specific biomarkers for the early prediction of CKD
progression. The recent application of innovative technologies such as functional genomics …

Diabetes mellitus (DM) is a public health problem worldwide. Despite the presence of
various sugar-lowering drugs, correcting hyperglycemia and preventing late DM …

We assessed the prognostic accuracy of urinary N-acetyl-β-D-glucosaminidase (NAG), an
early proximal tubular damage marker for the onset of diabetic nephropathy. The study …